Synopsis The safety committee was also looking at "serious thromboembolic events" from the UK. Sweden and Latvia on Tuesday joined Spain, Germany, France, Italy, Netherlands, Ireland, Denmark, Iceland, and Norway in the suspension of the use of AstraZeneca's COVID-19 vaccine. Agencies Meanwhile, the WHO and the European Medicines Agency have said that there was no indication of a connection between the jab and blood clots. There is no signal of concern regarding the use of Oxford-AstraZeneca COVID-19 vaccine in the country, said Dr V K Paul, Member (Health) of the Niti Aayog, on Wednesday amid speculations and subsequent review of possible side-effects of the vaccine.